Published in Lab Business Week, January 16th, 2005
Since September 2003, Arrowhead has funded research led by Collier in exchange for the option to exclusively license intellectual property generated through the research.
The Collier group is developing new technologies that could enable the control of individual molecules for revolutionary devices and systems in the life sciences and electronics industries. In 2004, Collier's team filed five...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week